Thromboembolism News and Research

RSS

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart failure, sinus rhythm, and coronary artery disease, according to late breaking results from the COMMANDER HF trial presented today in a Hot Line Session at ESC Congress 2018 and with simultaneous publication in NEJM.

27 Aug 2018

Oral anticoagulant use after hospital discharge may offer protection from non-fatal blood clots

The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.

27 Aug 2018

FDA approves first vaginal ring contraceptive that can be used for one year

The U.S. Food and Drug Administration today approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), which is a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire year.

10 Aug 2018

Transgender individuals may be at higher risk for cardiovascular disease

Transgender individuals may be at higher risk for myocardial infarction and death due to cardiovascular disease, according to several studies.

3 Aug 2018

Depression, antidepressant use linked with higher risk of venous thromboembolism

In the first review of its kind, new research has found that depression and the use of antidepressants are each associated with an increased risk of venous thromboembolism.

24 Jul 2018

Researchers develop new model for predicting cancer-associated venous thrombosis

In collaboration with international partners, a study group from the Medical University of Vienna has developed a new model for predicting cancer-associated venous thrombosis/pulmonary embolism.

11 Jul 2018

Direct oral anticoagulants associated with reduced risks of major bleeding

New drugs known as direct oral anticoagulants used to treat serious blood clots are associated with reduced risks of major bleeding compared with the older anti-clotting drug, warfarin, finds a study in The BMJ today.

5 Jul 2018

Risk of heart attacks, strokes and vascular occlusions found to be higher in cancer patients

It is well known that pre-existing cancer is a significant risk factor for venous thrombosis. What was hitherto unclear was whether cancer also has a negative impact upon the risk of heart attacks, strokes or occlusions of peripheral arteries.

25 Jun 2018

Oral drug reduces venous thromboembolism recurrence among cancer patients

Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.

11 May 2018

Study shows cardiovascular problems are more common in uterine cancer survivors

A new study in the Journal of the National Cancer Institute indicates that survivors of uterine cancer are more likely to experience cardiovascular problems years after treatment.

8 May 2018

International research consortium identifies 22 new genetic risk factors for stroke

An international research consortium studying 520,000 individuals from around the world has identified 22 new genetic risk factors for stroke, thus tripling the number of gene regions known to affect stroke risk.

13 Mar 2018

Research finds correlation between perioperative air travel and high risk of venous thromboembolism

New research presented at the 2018 Annual Meeting of the American Academy of Orthopaedic Surgeons found a correlation between flying following hip or knee arthroplasty and an increased risk of venous thromboembolism.

6 Mar 2018

Outpatient total knee replacement surgery linked to higher rates of complications

Some complications are more common when total knee replacement surgery is done as an outpatient or same-day procedure, reports a study in the December 6, 2017 issue of The Journal of Bone & Joint Surgery. The journal is published in partnership with Wolters Kluwer.

14 Dec 2017

FDA approves new drug to treat bleeding in hemophilia A patients

The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors.

17 Nov 2017

The more TV people watch, the greater the risk may be for venous thromboembolism

The risk of developing a blood clot in a vein increases the more time a person spends watching TV, even if they engage in the recommended amount of physical activity, according to research presented at the American Heart Association’s Scientific Sessions 2017, a global exchange of the latest findings in the field of cardiovascular science.

13 Nov 2017

UCR researchers elucidate how blood clots shrink

Blood clotting is the "Jekyll and Hyde" of biological processes. It's a lifesaver when you're bleeding, but gone awry, it causes heart attacks, strokes and other serious medical problems.

10 Nov 2017

Experts in obstetric care come together to realize quality measures for high-risk pregnancies

The United States spends significantly more money on the delivery of health care yet experiences inferior results. Maternal and infant mortality rates are elevated in the United States as compared to other high-income nations.

11 Oct 2017

FDA approves Verzenio for advanced metastatic breast cancer

The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.

2 Oct 2017

Study finds strong link between height and VTE risk

In a new study from Lund University in Sweden, researchers investigated the risk factors for blood clots, i.e. venous thromboembolism (VTE). The results show a strong correlation between height and VTE risk for both women and men. The risk increases with height.

11 Sep 2017

Study reveals link between increased height and blood clots in vein

A new study published in the Circulation: Cardiovascular Genetics – a journal of the American Heart Association – suggested that there is an increased probability of developing blood clots in the veins with an increase in height.

6 Sep 2017